NFA
INSY

Nationwide Fund Advisors’s Insys Therapeutics, Inc. INSY Stock Holding History

Nationwide Fund Advisors’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-13,506
Closed -$120K – 2810
2017
Q3 		$120K Hold
13,506
– – ﹤0.01% 2832
2017
Q2 		$171K Hold
13,506
– – ﹤0.01% 2692
2017
Q1 		$142K Sell
13,506
-1,677
-11% -$17.9K ﹤0.01% 2726
2016
Q4 		$140K Hold
15,183
– – ﹤0.01% 2760
2016
Q3 		$179K Hold
15,183
– – ﹤0.01% 2678
2016
Q2 		$196K Hold
15,183
– – ﹤0.01% 2619
2016
Q1 		$243K Sell
15,183
-289
-2% -$5.49K ﹤0.01% 2442
2015
Q4 		$443K Sell
15,472
-62,305
-80% -$1.73M ﹤0.01% 2168
2015
Q3 		$2.21M Buy
77,777
+62,500
+409% +$2.3M 0.01% 1307
2015
Q2 		$549K Buy
15,277
+605
+4% +$18.8K ﹤0.01% 2197
2015
Q1 		$426K Sell
14,672
-502
-3% -$13.3K ﹤0.01% 2317
2014
Q4 		$320K Sell
15,174
-240
-2% -$4.75K ﹤0.01% 2425
2014
Q3 		$299K Buy
15,414
+44
+0.3% +$691 ﹤0.01% 2500
2014
Q2 		$240K Buy
15,370
+3,580
+30% +$57.9K ﹤0.01% 2657
2014
Q1 		$244K Hold
11,790
– – ﹤0.01% 2401
2013
Q4 		$152K Sell
11,790
-303
-3% -$4.2K ﹤0.01% 2809
2013
Q3 		$141K Sell
12,093
-179,091
-94% -$1.47M ﹤0.01% 2833
2013
Q2 		$882K Buy
+191,184
New +$701K ﹤0.01% 1739

Other funds holding INSY

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nationwide Fund Advisors's INSY Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Insys Therapeutics, Inc. (INSY) in Q4 2017, closing a stake of 13,506 shares — an estimated $120K sold.

Nationwide Fund Advisors first reported a position in INSY in Q2 2013 and held it in 18 quarters. The position peaked at $2.21M in Q3 2015. 112 funds tracked by Wall St. Rank hold INSY as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Insys Therapeutics, Inc. position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 13,506 Insys Therapeutics, Inc. shares in Q4 2017, an estimated $120K.
  • Nationwide Fund Advisors first reported a position in Insys Therapeutics, Inc. in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's Insys Therapeutics, Inc. position peaked at $2.21M in Q3 2015.
  • 112 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.